Investing.com - Qiagen reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Qiagen announced earnings per share of $0.5007 on revenue of $461.82M. Analysts polled by Investing.com anticipated EPS of $0.4581 on revenue of $425.46M.
Qiagen shares are up 12% from the beginning of the year and are trading at $47.635 , down-from-52-week-high.They are under-performing the DAX which is up 16.34% from the start of the year.
Qiagen follows other major Healthcare sector earnings this month
Qiagen's report follows an earnings beat by Fresenius SE on Tuesday, who reported EPS of $0.78 on revenue of $9.32B, compared to forecasts EPS of $0.7687 on revenue of $9.3B.
Fresenius Medical Care had missed expectations on Tuesday with third quarter EPS of $0.94 on revenue of $4.44B, compared to forecast for EPS of $0.9476 on revenue of $4.53B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar